69 results
Page 2 of 4
F-3
3ge34r oe4mwx
3 May 22
Shelf registration (foreign)
7:25pm
F-3
EX-5.1
nfyj4g
3 May 22
Shelf registration (foreign)
7:25pm
424B3
igof7mvwlq283
3 May 22
Prospectus supplement
4:55pm
F-3
uk5 og5txpj5pgh34o
14 Apr 22
Shelf registration (foreign)
9:30pm
6-K
EX-99.1
vkhvfmkh57s779wg6g
11 Jan 22
Autolus Therapeutics announces retirement of chief financial officer and succession plan
4:33pm
6-K
EX-99.1
vyme71qo63ftqb4e05wo
8 Nov 21
Securities Purchase Agreement
5:28pm
6-K
EX-99.3
9wulhhltmqgzcws es
8 Nov 21
Securities Purchase Agreement
5:28pm
424B5
4uama
19 Aug 21
Prospectus supplement for primary offering
4:13pm
F-3
0orjvay4ezyoaa66x 4w
6 Aug 21
Shelf registration (foreign)
2:30pm
6-K
EX-1
i43cne5io7ium4o8m
30 Jun 21
Annual Report and Accounts
6:05am
6-K
EX-1.1
rvy8t8oawngii4
11 Feb 21
Autolus Announces Proposed Public Offering in the United States
5:18pm
424B5
ajgmm
11 Feb 21
Prospectus supplement for primary offering
5:16pm
424B5
u9vuw1
8 Feb 21
Prospectus supplement for primary offering
5:27pm
424B5
76u81g
18 Sep 20
Prospectus supplement for primary offering
8:01am
6-K
EX-5.1
5mm qzdfc3v0v3u
18 Sep 20
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ESMO
7:12am
6-K
EX-1.1
8gh am3r4
18 Sep 20
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ESMO
7:12am
6-K
EX-1
2vxfhoj2baxoqrnh652i
26 May 20
Current report (foreign)
4:31pm